81 related articles for article (PubMed ID: 28776076)
21. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA; Harari PM; Giralt J; Azarnia N; Shin DM; Cohen RB; Jones CU; Sur R; Raben D; Jassem J; Ove R; Kies MS; Baselga J; Youssoufian H; Amellal N; Rowinsky EK; Ang KK
N Engl J Med; 2006 Feb; 354(6):567-78. PubMed ID: 16467544
[TBL] [Abstract][Full Text] [Related]
23. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.
Forastiere AA; Goepfert H; Maor M; Pajak TF; Weber R; Morrison W; Glisson B; Trotti A; Ridge JA; Chao C; Peters G; Lee DJ; Leaf A; Ensley J; Cooper J
N Engl J Med; 2003 Nov; 349(22):2091-8. PubMed ID: 14645636
[TBL] [Abstract][Full Text] [Related]
24. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.
Overgaard J; Hansen HS; Specht L; Overgaard M; Grau C; Andersen E; Bentzen J; Bastholt L; Hansen O; Johansen J; Andersen L; Evensen JF
Lancet; 2003 Sep; 362(9388):933-40. PubMed ID: 14511925
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
Pignon JP; Bourhis J; Domenge C; Designé L
Lancet; 2000 Mar; 355(9208):949-55. PubMed ID: 10768432
[TBL] [Abstract][Full Text] [Related]
26. T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone.
Mendenhall WM
Semin Radiat Oncol; 1998 Oct; 8(4):262-9. PubMed ID: 9873104
[TBL] [Abstract][Full Text] [Related]
27. T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage.
Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):549-52. PubMed ID: 9486603
[TBL] [Abstract][Full Text] [Related]
28. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.
Dische S; Saunders M; Barrett A; Harvey A; Gibson D; Parmar M
Radiother Oncol; 1997 Aug; 44(2):123-36. PubMed ID: 9288840
[TBL] [Abstract][Full Text] [Related]
29. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
[TBL] [Abstract][Full Text] [Related]
30. [The incidence of laryngeal cancer among males in the upper Silesia].
Zemła B; Weryński M; Sowa J; Markiewicz L; Ihnatowicz J
Otolaryngol Pol; 1996; 50(3):248-52. PubMed ID: 9045161
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in T3,N0-1 glottic and transglottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy.
Kowalski LP; Batista MB; Santos CR; Scopel A; Salvajolli JV; Torloni H
Arch Otolaryngol Head Neck Surg; 1996 Jan; 122(1):77-82. PubMed ID: 8554750
[TBL] [Abstract][Full Text] [Related]
32. Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration.
Skladowski K; Law MG; Maciejewski B; Steel GG
Radiother Oncol; 1994 Feb; 30(2):109-20. PubMed ID: 8184108
[TBL] [Abstract][Full Text] [Related]
33. T4NOMO glottic cancer: an analysis of dose-time volume factors.
Harwood AR; Beale FA; Cummings BJ; Keane TJ; Payne D; Rider WD
Int J Radiat Oncol Biol Phys; 1981 Nov; 7(11):1507-12. PubMed ID: 7333899
[No Abstract] [Full Text] [Related]
34. Stomal recurrence. A critical analysis of risk factors.
Mantravadi R; Katz AM; Skolnik EM; Becker S; Freehling DJ; Friedman M
Arch Otolaryngol; 1981 Dec; 107(12):735-8. PubMed ID: 7316854
[TBL] [Abstract][Full Text] [Related]
35. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx.
Maciejewski B; Preuss-Bayer G; Trott KR
Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):321-8. PubMed ID: 6841183
[TBL] [Abstract][Full Text] [Related]
36. Definitive irradiation of T1-T4N0 larynx cancer.
Chacko DC; Hendrickson FR; Fisher A
Cancer; 1983 Mar; 51(6):994-1000. PubMed ID: 6821874
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma of the larynx and hypopharynx: computed tomographic-histopathologic correlations.
Silverman PM; Bossen EH; Fisher SR; Cole TB; Korobkin M; Halvorsen RA
Radiology; 1984 Jun; 151(3):697-702. PubMed ID: 6718729
[TBL] [Abstract][Full Text] [Related]
38. Radiation treatment of lateral epilaryngeal cancer. Prognostic factors and results.
Bataini JP; Brugere J; Jaulerry CH; Brunin F; Bernier J; Ghossein NA
Am J Clin Oncol; 1984 Dec; 7(6):641-5. PubMed ID: 6442098
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma of the supraglottic larynx treated with radical irradiation: analysis of treatment parameters and results.
Mendenhall WM; Million RR; Cassisi NJ
Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2223-30. PubMed ID: 6439701
[TBL] [Abstract][Full Text] [Related]
40. Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients.
Harwood AR; Beale FA; Cummings BJ; Keane TJ; Payne DG; Rider WD; Rawlinson E; Elhakim T
Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):311-9. PubMed ID: 6404867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
